Immunology and Microbiology
Herpes Simplex Virus 2
100%
Herpes Simplex Virus
76%
Glycoprotein
61%
Monospecific Antibody
42%
Microbicide
35%
Wild Type
32%
Viral Disease
30%
Human Immunodeficiency Virus
29%
Viral Entry
26%
Defensin
26%
Viral Protein
21%
Mouse
20%
Genital Herpes
19%
Capsid
19%
Humoral Immunity
19%
Neutrophil
17%
Leukocyte
17%
T-Helper Cell
17%
Low Drug Dose
17%
Nonoxynol-9
17%
Antiserum
16%
Subunit Vaccine
16%
Cell Mediated Cytotoxicity
16%
Neonatal Fc Receptor
16%
Fc Receptor
16%
Titer
16%
interferon
16%
Virus Type
16%
SCID Mouse
16%
Bagg Albino Mouse
16%
Knockout Mouse
16%
Live Vaccine
16%
Attenuated Vaccine
16%
Innate Immune System
14%
Seminal Plasma
14%
Secretion (Process)
14%
Calcium Cell Level
12%
Human Immunodeficiency Virus 1
12%
Mediator
11%
Upregulation
11%
Tenofovir
11%
Immediate Early Gene
11%
Neutralizing Antibody
11%
Severe Acute Respiratory Syndrome Coronavirus 2
10%
Immune Response
10%
Polysome
10%
Antimicrobial Activity
10%
Antibody Titer
10%
Angiogenin
10%
Japanese Encephalitis Virus Group
10%
Pharmacology, Toxicology and Pharmaceutical Science
Herpes Simplex Virus 2
50%
Microbicide
42%
Herpes Simplex Virus
42%
Glycoprotein D
35%
Neurologic Disease
32%
Fc Receptor
32%
Skin Disease
32%
HIV
32%
Vagina Disease
32%
Cytotoxicity
24%
Infection
22%
Disease
21%
Genital Herpes
19%
Subunit Vaccine
16%
SCID Mouse
16%
Bagg Albino Mouse
16%
Knockout Mouse
16%
Live Vaccine
16%
Antibodies
16%
Antiserum
16%
Antivirus Agent
14%
Virus Infection
13%
Cellulose Sulfate
13%
Antiviral Activity
12%
Mouse
12%
Placebo
12%
Mandelic Acid
10%
Biological Marker
10%
DNA
10%
Miltefosine
10%
Nectin 1
10%
Interferon
10%
Initiation Factor 3
10%
Receptor
10%
Cotton Rat
10%
Viral Protein
10%
Nonoxynol-9
10%
Glycoprotein B
9%
Clinical Trial
8%
Human Immunodeficiency Virus 1
8%
Tenofovir
7%
Confocal Microscopy
6%
Etoposide
5%
Cell Protein
5%
Small Interfering RNA
5%
Albino Mouse
5%
Epileptic Absence
5%
Hydroxyethyl Cellulose
5%
Keyphrases
Herpes Simplex Virus
34%
Neural Diseases
32%
Herpes Simplex Virus 2 (HSV-2)
29%
Virus
26%
Herpes Simplex Virus Infection
24%
Cervicovaginal Lavage
24%
Glycoprotein D
23%
Skin Diseases
21%
Vaginal Diseases
21%
Herpes Simplex Type 2
21%
Cervical mucus
16%
AIDS/HIV
15%
Human Neutrophil Antigens
13%
Innate Immunity
11%
Herpes Simplex Virus Type 1 (HSV-1)
11%
Mandelic Acid
10%
Acid Condensation
10%
Condensation Polymers
10%
Neutralizing Activity
10%
Genital Tract
10%
Knock-in Mouse Model
10%
Passive Transfer
10%
Virus-cell Fusion
10%
Protective Antigen
10%
Non-neutralizing
10%
C57BL
10%
Immune Mediators
10%
Balb C Mice
10%
Secretory Leukocyte Protease Inhibitor
10%
Immune Escape
10%
Serum Titers
10%
Eukaryotic Initiation Factor 3
10%
Subunit Vaccine
10%
Immune Serum
10%
Antimicrobial Activity
10%
Human Angiogenin
10%
Angiogenin
10%
Synthetic Gene
10%
Latency
10%
Virus Entry
10%
Focal Adhesion Kinase
10%
Intercellular Spread
10%
Fc Receptor
10%
DNA Polymers
10%
Anti-HSV Activity
10%
Adaptor
10%
Double-blind Placebo-controlled Trial
10%
Recombinant Vaccinia Virus
10%
Japanese Encephalitis Virus
10%
Stimulator of Interferon Genes (STING)
10%